<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2025.1512669</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Nutrition</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Comparative analysis of proteomics and transcriptomics reveals novel mechanism underlying the antibacterial activity and immune-enhancing properties of horse milk</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Chen</surname> <given-names>Xueshan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2871113/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Gulbahar</surname> <given-names>Kawuli</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ding</surname> <given-names>Haiyan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Nie</surname> <given-names>Changhong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gao</surname> <given-names>Xiaoli</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1371239/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>School of Pharmacy, Xinjiang Medical University</institution>, <addr-line>Xinjiang</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Xinjiang Medical University</institution>, <addr-line>Xinjiang</addr-line>, <country>China</country></aff>
<author-notes>
<fn id="fn0004" fn-type="edited-by"><p>Edited by: Lei Chen, Guangdong Ocean University, China</p></fn>
<fn id="fn0005" fn-type="edited-by"><p>Reviewed by: Mohammed Abu El-Magd, Kafrelsheikh University, Egypt</p>
<p>Csaba Olah, Independent Researcher, S&#x00E1;rospatak, Hungary</p>
<p>Zipeng Jiang, Zhejiang University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Xiaoli Gao, <email>xli_g@sina.com</email></corresp>
<corresp id="c002">Xueshan Chen, <email>chenxueshan2010@sina.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>03</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1512669</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>02</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Chen, Gulbahar, Ding, Nie and Gao.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Chen, Gulbahar, Ding, Nie and Gao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Horse milk is a highly valuable organic food that is a promising alternative to cow milk, exhibiting plenty of healthy and immune benefits to human. However, identification of proteins associated human wellness and underlying molecular mechanism in horse milk remain unclear.</p>
</sec>
<sec id="sec2">
<title>Methodology</title>
<p>Label-free mass spectrometry-based protein quantification technology was employed to investigate protein composition of animal milk, including cow, goat, camel and horse milk. Prokaryotic expression and disk diffusion assay were applied to acquire and evaluate <italic>in vitro</italic> antimicrobial activity of candidate proteins. RAW264.7 macrophage model cell line was used to validate effect of proteins on cytotoxicity, apoptosis and immune induction. ROS probe detected cell ROS change and RT-qPCR verified expression of immune response genes induced by proteins. Microscopy was used to observe the effects of protein on the morphological characteristics of bacteria, further transcriptome analysis was performed to investigate transcriptional changes of bacteria induced by candidate proteins.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>A total of 1,335 proteins was identified in cow, goat, camel and horse milk. GO enrichment analysis showed that the proteins related to protein degradation were highly expressed in horse milk compared to other three types of milk, contributing to easier assimilation and palatability. KEGG analysis showed that horse milk contained abundant antimicrobial associated proteins relevant to pathogenic bacterial resistance, leading to the decreased risk of pathogenic diseases. A higher accumulation of proteins associated with caffeine metabolism, amino acid biosynthesis, and glycolysis/gluconeogenesis in horse milk contributes to its distinctive flavor. Notably, highly expressed proteins in horse milk were closely linked to immune signaling pathways, functioning as immune modulators. Importantly, we identified four highly expressed antimicrobial associated proteins in horse milk including LPO, B2M, CD14 and PGL, among them, PGL functioned dually by <italic>in vitro</italic> antibacterial activity and immune activation. Further transcriptome analysis demonstrated that PGL exerted significant transcriptional changes to bacteria. Enrichment analysis showed PGL could inhibit growth of <italic>P. aeruginosa</italic> and <italic>E. coli</italic> by repressing the biosynthesis of secondary metabolites.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>Comparative proteomics revealed immune enhancement and nutrient composition of horse milk compared to cow, goat and camel milk. Identification of PGL showed antibacterial activity and potential medicinal value.</p>
</sec>
</abstract>
<kwd-group>
<kwd>horse milk</kwd>
<kwd>camel milk</kwd>
<kwd>goat milk</kwd>
<kwd>cow milk</kwd>
<kwd>proteomics</kwd>
<kwd>transcriptomics</kwd>
<kwd>antimicrobial activity</kwd>
<kwd>immune induction</kwd>
</kwd-group>
<counts>
<fig-count count="11"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="54"/>
<page-count count="20"/>
<word-count count="10906"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nutrition and Food Science Technology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<title>Introduction</title>
<p>Milk is a unique substance secreted by the mammary glands of mammals to feed their offspring, and is the perfect food for survival and development after birth (<xref ref-type="bibr" rid="ref1">1</xref>). Besides human breastmilk, the human habit of consuming milk derived from animal like cow and sheep survived thousands of years and early documented at the Neolithic Age (<xref ref-type="bibr" rid="ref2">2</xref>). To date, the global milk production of dairy livestock has increased from 522 million tons to 937 million tons from 1987 to 2022, reaching an increase of about 80% (<xref ref-type="bibr" rid="ref3">3</xref>). Despite the cow milk still had the predominant occupation in milk production, approximately 82% (<xref ref-type="bibr" rid="ref4">4</xref>, <xref ref-type="bibr" rid="ref5">5</xref>), increasing demands for different nutrient compositions in dairy products also facilitated the exploration of other animal derived milk like camel, buffalo, sheep and horse (<xref ref-type="bibr" rid="ref6">6</xref>&#x2013;<xref ref-type="bibr" rid="ref9">9</xref>). Therefore, the researchers take an interest in finding out the value of nutrient and economic in other alternative milk products in current studies.</p>
<p>Horse milk is a promising and valuable dietary resource of dairy products. The inhabitants lived in central Asia and parts of Europe like Holland and Balkan region that consumed horse milk as daily food (<xref ref-type="bibr" rid="ref10">10</xref>). The nutrient composition and proportions of horse milk are similar with those of human breast milk, including the small proteins (<italic>&#x03B2;</italic>-lactoglobulins and <italic>&#x03B1;</italic>-lactoalbumin), lactose, minerals and microelements (<xref ref-type="bibr" rid="ref11">11</xref>). Horse milk has an elevated lactose content, excellent palatability, and promotes intestinal calcium absorption, which may contribute to mineralization in children (<xref ref-type="bibr" rid="ref12">12</xref>). In terms of levels of protein and inorganic content, horse&#x2019;s milk has a kidney load comparable to that of human milk, implying its economic prospects for infant food (<xref ref-type="bibr" rid="ref13">13</xref>). The activity and variety of prebiotics and probiotics in horse milk are potentially beneficial for infants and children with cow&#x2019;s milk protein allergies (CMPA) and intolerances to multiple food ingredients (<xref ref-type="bibr" rid="ref9">9</xref>, <xref ref-type="bibr" rid="ref14">14</xref>). Notably, horse milk was fermented with bacteria and yeasts, forming alcoholic beverages, also called qymyz or koumiss, with unique flavor and taste which shows an appealing trend to consumers (<xref ref-type="bibr" rid="ref15">15</xref>). Therefore, these studies proposed that horse milk could serve as an excellent alternative of breastmilk and beverage with low digestive burden (<xref ref-type="bibr" rid="ref16">16</xref>).</p>
<p>Growing evidence now indicated that moderate consumption of horse milk provides significant health benefits across different stages of life (<xref ref-type="bibr" rid="ref17">17</xref>). The health benefits of horse milk are largely attributed to its higher concentrations of bioactive proteins, such as lactotransferrin (LTF), peptidoglycan recognition protein (PGRP1), and whey acidic protein (WAP), compared to milk from other species, including goat, cow, and buffalo (<xref ref-type="bibr" rid="ref12">12</xref>). For instance, the replenishment of horse milk could enhance the glycogen level in liver and muscle contributing to the improvement of exercise-induced fatigue (<xref ref-type="bibr" rid="ref13">13</xref>). Regular consumption of horse milk may help adults lower the risk of chronic diseases, including metabolic syndrome (<xref ref-type="bibr" rid="ref18">18</xref>), cardiovascular disease (<xref ref-type="bibr" rid="ref19">19</xref>), and type II diabetes (<xref ref-type="bibr" rid="ref20">20</xref>). Especially in the elderly, it could enhance cognitive function, preserve skeletal muscle quality, and reduce the risk of frailty and sarcopenia (<xref ref-type="bibr" rid="ref21">21</xref>). Besides, animal milk can secret milk-derived exosomes (MDEs) containing multiple bioactive molecules such as proteins, microRNAs, and lipids, contributing to intercellular communication and potential immunomodulatory effects (<xref ref-type="bibr" rid="ref22">22</xref>&#x2013;<xref ref-type="bibr" rid="ref24">24</xref>). Sedykh et al. (<xref ref-type="bibr" rid="ref25">25</xref>) identified several bioactive components like CD81, CD63 receptors, beta-lactoglobulin and lactadherin in horse milk, which function immune contributions to human. Despite such nutritional evidence emphasized the importance of horse milk consumption, limited processing technologies, unknown bioactive components and low production remain in economic promotion of horse milk.</p>
<p>Over the past years, substantial advances have been made in composition determination of various food stuff that is beneficial to human health by proteomic strategy. Proteomic technologies ensure the large-scale and in-depth investigation of proteins, in particular, the determination of potential bioactive substance in complex biological materials by means of a high-throughput manner (<xref ref-type="bibr" rid="ref26">26</xref>). Renzone et al. (<xref ref-type="bibr" rid="ref27">27</xref>) detected the quality of advanced glycation end-products (AGE) in various infant formula milk by proteomics analysis which contributed to the risk assessment of infant formula milk. Proteomics analysis of Australian camel milk in different seasons elucidated that summer camel milk contained more abundant accumulation of whey proteins resulting in high nutritional value and easier assimilation (<xref ref-type="bibr" rid="ref28">28</xref>). Hitherto, few studies have systematically identified bioactive protein components in horse milk. In this study, we used the label-free protein identification approach to quantify and assess difference in proteomes among horse milk, cow milk, goat milk and camel milk. We aimed to investigate major bioactive components and characterized chemical properties of horse milk compared to other types of animal milk. These proteins could be exploited as nutritional marks to highlight the value of horse milk and avail of horse milk promotion. Further identification of antimicrobial associated proteins in horse milk illustrated their immune contributions on inhibitory effect for multiple pathogens and enhancement of host immunity. These findings provide a valuable insight to horse milk protein constitution and immune benefits for further promotion of horse milk.</p>
</sec>
<sec sec-type="materials|methods" id="sec6">
<title>Materials and methods</title>
<sec id="sec7">
<title>Sample collection and preparation</title>
<p>Milk samples were collected from Horse (<italic>Equus caballus</italic>), cow (<italic>Bos taurus</italic>), goat (<italic>Capra hircus</italic>), and camel (<italic>Camelus bactrianus</italic>) at 2 weeks after parturition after 2 weeks. Lactating horses were 3&#x202F;years old, cows were 2&#x202F;years old, goats were 3&#x202F;years old and camels were 5&#x202F;years old, which were selected from a local farm in Nanshan region in Xinjiang. All animals were maintained under standardized dietary and environmental conditions, following established husbandry guidelines. The animals were housed in controlled environments with consistent access to water, regulated temperature, and standardized management practices to reduce external influences on milk composition. Each milk sample was a mixture of milk from three animal individuals and each type of milk sample contained three replicates. A total of 200&#x202F;mL milk samples was centrifuged at 11,000 r/min for 20&#x202F;min at 4&#x00B0;C and the upper fat part was carefully discarded. And then, rest solution was freeze-dried into powder by Freeze-Drying Digital Unit (MODULYOD-230) and stored at &#x2212;80&#x00B0;C, preparing for further analysis.</p>
</sec>
<sec id="sec8">
<title>Sample preparation for label-free proteomic quantification</title>
<p>A total of 5&#x202F;mL of SDT cracking solution (sodium dodecyl sulfate, 4% v/v, SDS, dithiothreitol, DTT and Tris&#x2013;HCl, 100&#x202F;mM, pH&#x202F;=&#x202F;7.6) was added to samples of milk from four groups, boiling water bath for 5&#x202F;min. Then, samples were centrifuged at 14,000 g for 15&#x202F;min, and supernatant was taken and stored at &#x2212;80&#x00B0;C for proteome analysis. The protein quantification was detected using BCA method. Take 200 &#x03BC;g protein solution of each sample, add DTT to the final concentration of 100&#x202F;mM, then boil in water for 5&#x202F;min, cool to room temperature. Then the solution samples were mixed with 200&#x202F;&#x03BC;L UA buffer (urea, 8&#x202F;M, Tris&#x2013;HCl, 100&#x202F;mM, pH&#x202F;=&#x202F;8.5) then transferred to the ultrafiltration centrifuge tube for centrifugation at 14,000 g for 15&#x202F;min (repeat this step once), and the filtrate was discarded. Subsequently, 100&#x202F;&#x03BC;L IAA buffer (100&#x202F;mM IAA in UA) was added to the solution and shake at 600&#x202F;rpm for 1&#x202F;min, then the samples were kept at 28&#x00B0;C for 30&#x202F;min before centrifugation at 14,000 g for 15&#x202F;min. After centrifugation, 100&#x202F;&#x03BC;L UA buffer was added, and the samples were centrifuged at 14,000 g for 15&#x202F;min, and the procedure was repeated twice. In total, 100&#x202F;&#x03BC;L 25&#x202F;mM NH<sub>4</sub>HCO<sub>3</sub> solution was added, centrifuged at 14,000 g for 15&#x202F;min, and the procedure was repeated twice. Then, 40&#x202F;&#x03BC;L Trypsin buffer (4 &#x03BC;g Trypsin in 40&#x202F;&#x03BC;L 100&#x202F;mM NH<sub>4</sub>HCO<sub>3</sub>) was added into each sample, shake at 600&#x202F;rpm for 1&#x202F;min, then the samples were kept at 37&#x00B0;C for 16&#x2013;18&#x202F;h. All samples were taken into another collection tube, and centrifuged at 14,000 g for 15&#x202F;min; Then 40&#x202F;&#x03BC;L 25&#x202F;mM NH<sub>4</sub>HCO<sub>3</sub> was added and centrifuged at 14,000 g for 15&#x202F;min to collect filtrate. C<sub>18</sub> Cartridge was used to desalinate the peptide. After lyophilization, the peptide was redissolved with 40&#x202F;&#x03BC;L 0.1% formic acid solution, and the peptide was quantified with optical density at 280 (OD<sub>280</sub>).</p>
</sec>
<sec id="sec9">
<title>Protein identification by LC&#x2013;MS/MS</title>
<p>According to the quantitative results, 2&#x202F;&#x03BC;g enzymolysis products were taken for LC&#x2013;MS/MS analysis (Q-Exactive). HPLC system Easy nLC was used for separation. Solution Buffer A is 0.1% formic acid, and solution B is 0.1% formic acid acetonitrile aqueous solution (acetonitrile is 84%). The column was balanced with 95% solution A. The samples were loaded into the Thermo Scientific EASY Column (2&#x202F;cm&#x002A;100&#x202F;&#x03BC;m 5&#x202F;&#x03BC;m-C<sub>18</sub>), and then analyzed on a Thermo Scientific EASY Column (75&#x202F;&#x03BC;m&#x002A;100&#x202F;mm 3&#x202F;&#x03BC;m-C<sub>18</sub>) at a flow rate of 300&#x202F;nL/min. The solution gradient is as follows: 0&#x2013;110&#x202F;min, linear gradient of liquid B ranges from 0 to 55%; 110&#x2013;115&#x202F;min, the linear gradient of liquid B increased from 55 to 100%; 115 to 120&#x202F;min, liquid B was maintained at 100%. The peptides were separated by chromatography and analyzed by MASS spectrometry using Q-Exactive Mass spectrometer (Thermo Scientific). Detection method: positive ion; Scanning range of parent ion: 300&#x2013;1,800&#x202F;m/z; Primary mass spectrometry resolution: 70,000 at 200&#x202F;m/z; The peptide fragments was collected according to the following methods: 20 fragments were collected after each Full scan (MS2 Scan), and the resolution of MS was 17,500 at 200&#x202F;m/z. Microscans: 1, Isolation Window: 2&#x202F;m/z, Maximum IT: 60&#x202F;ms, MS2 Activation Type:HCD, Normalized Collision Energy: 27&#x202F;eV, Dynamic Exclusion: 60.0&#x202F;s, Underfillratio: 0.1%.</p>
</sec>
<sec id="sec10">
<title>Data processing and enrichment analyses</title>
<p>The resulting MS/MS data were processed using MaxQuant search engine (vs 1.6.3.3) (<xref ref-type="bibr" rid="ref29">29</xref>). Tandem mass spectra were searched against the UniProt database concatenated with reverse decoy database. Trypsin/P was specified as cleavage enzyme allowing up to 2 max missing cleavages. The mass tolerance for precursor ions was set as 20&#x202F;ppm in First search and 6&#x202F;ppm in Main search, and the mass tolerance was 20&#x202F;ppm. Carbamidomethyl on Cys was specified as fixed modification and acetylation modification and oxidation on Met were specified as variable modifications.</p>
<p>For protein quantification, label-free quantification (LFQ) was used. The fundamental bioinformatics analyses, including PCA, Pearson correlation and volcano plot analysis, which were conducted using an online cloud-based platform.<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> Statistical analysis of protein differences was performed using a paired t-test in Perseus (version 1.6.14.0). A significance threshold of <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 and a |Log<sub>2</sub>FoldChange|&#x202F;&#x003E;&#x202F;1.0 were applied to identify significantly differentially expressed proteins. KEGG pathway and Gene Ontology (GO) enrichment analyses were conducted to classify the differentially expressed proteins. Fisher&#x2019;s exact test was used to assess the enrichment of differentially expressed proteins in each category. GO terms and KEGG pathways with <italic>p</italic>-value &#x003C;0.05 were considered significant.</p>
</sec>
<sec id="sec11">
<title>Transcriptome analysis</title>
<p>The testing samples were delivered to Allwegene (Nanjing, China) for RNA isolation, and raw data processing was performed using the Allwegene online cloud platform.<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref> For alignment, the clean reads were mapped to the reference genome using the HISAT2 aligner (version 2.2.1). The resulting aligned reads were then normalized using the RSEM (version 1.3.1) tool to account for gene length and sequencing depth biases. Differential expression analysis was performed using the DESeq2 R package (version 1.10.1). DESeq2 performs differential expression analysis by fitting a generalized linear model (GLM) based on a negative binomial distribution. Normalization of read counts was performed using DESeq2 built-in method, which accounts for library size differences between samples. The resulting <italic>p</italic>-values were adjusted using the Benjamini-Hochberg method to control the false discovery rate (FDR). Genes with an adjusted <italic>p</italic>-value &#x003C;0.05 were considered significantly differentially expressed.</p>
<p>Gene Ontology (GO) analysis was performed using the GOseq R package (version 3.21), which corrects for gene length biases. GO terms were categorized into Molecular Function (MF), Biological Process (BP), and Cellular Component (CC). KEGG pathway analysis was carried out using KOBAS 3.0 software to test the statistical enrichment of differentially expressed genes (DEGs) in KEGG pathways. GO terms and KEGG pathways with a corrected <italic>p</italic>-value &#x003C;0.05 were considered significantly enriched.</p>
</sec>
<sec id="sec12">
<title>Prokaryotic expression and protein purification</title>
<p>For prokaryotic expression assay, the coding sequences of PGL, CD14, B2M and LPO were fused with glutathione S-transferase (GST) tag in pGEX-4&#x202F;T-1 plasmid (kept in local lab, sequence was abstracted from SnapGene 7.1.0) with double-digested by the BamH I and EcoR I sites. Then recombinant plasmids of four proteins were transformed into <italic>Escherichia coli</italic> Rosetta Gami 2 and the transformants were chosen to produce GST-fusion proteins. Recombinant protein expression was induced with 0.4&#x202F;mM isopropyl-<italic>&#x03B2;</italic>-D-1-thiogalactopyranoside (IPTG) and continuous cultivation in incubator at 18&#x00B0;C, 160&#x202F;rpm. After 16&#x202F;h, <italic>E. coli</italic> cells were collected and cleaned in suspension buffer (10&#x202F;mM Tromethamine-HCl, pH 7.4, 50&#x202F;mM NaCl). Samples of the <italic>E. coli</italic> suspension culture was pulverized with ultrasound for 20&#x202F;min and then centrifugated at 12,000 g, 1&#x202F;h, 4&#x00B0;C. The collected supernatant was purified with GST resin (Sangon, C600912) at 4&#x00B0;C for 1&#x202F;h in an overhead shaker. The supernatant was then discarded, and the remaining beads were rinsed with glutathione buffer three times before collection. Then sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to identify whether the target proteins were expressed. Purified recombinant proteins were added to SDS-PAGE loading buffer, boiled, and centrifuged. The supernatants were subjected to PAGE, and the proteins were transferred to polyvinylidene difluoride membranes. The membranes were incubated with the indicated antibodies in protocols.</p>
</sec>
<sec id="sec13">
<title>Antimicrobial activity <italic>in vitro</italic></title>
<p>A bacterial suspension with 1&#x202F;&#x00D7;&#x202F;10<sup>4</sup>&#x202F;CFU/mL was evenly spread onto agar plates (100&#x202F;&#x03BC;L per plate) and allowed to adsorb for 5&#x202F;min. Recombinant proteins were lyophilized by Freeze-Drying Digital Unit (MODULYOD-230) and reconstituted to a final concentration of 200&#x202F;mg/L. Protein concentration was determined using the Bradford protein assay (BSA) (Sangon biotech, Shanghai). A BSA standard curve was prepared by serial dilution of a BSA stock solution, and the absorbance was measured at 595&#x202F;nm using a spectrophotometer. Ampicillin sodium (50&#x202F;&#x03BC;g/mL) served as the positive control and GST protein served as the negative control. Sterile paper discs (0.5&#x202F;cm diameter) were loaded with 12&#x202F;&#x03BC;L of either the protein solution or the control. The discs were aseptically placed onto the agar surface using flame-sterilized tweezers, ensuring firm contact with the medium. Each bacterial strain was tested in triplicate, with three independent replicates. Plates were incubated at 37&#x00B0;C for 16&#x2013;24&#x202F;h, and the diameter of inhibition zones was measured using a ruler. The inhibitory effectiveness was evaluated by subtracting the paper disc diameter from the inhibition zone diameter.</p>
</sec>
<sec id="sec14">
<title>RNA extraction and RT-qPCR assays</title>
<p>The RNA of RAW264.7 cell was extracted using the TRIzol method (Invitrogen, CA, United States) and treated with RNase-free DNase I (Takara, Kusatsu, Japan). Total RNA (2&#x202F;&#x03BC;g) was reverse-transcribed to cDNA in a 20&#x202F;&#x03BC;L reaction mixture using a SPARKscript II RT Plus.</p>
<p>Kit (SparkJade, Jinan, China). The qPCR instructions were conducted as described by Jia et al. (<xref ref-type="bibr" rid="ref30">30</xref>). The primers used for qPCR are listed in <xref rid="SM1" ref-type="supplementary-material">Supplementary Table S1</xref>. The internal control was used as GAPDH (Accession number: NM_001256799.3).</p>
</sec>
<sec id="sec15">
<title>Cell culture, apoptosis staining, and detection assays</title>
<p>RAW264.7 cells were obtained from China Center for Type Culture Collection (CCTCC, Wuhan, China) and grown in Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM) using 12-well plates and treated with 500&#x202F;&#x03BC;M H<sub>2</sub>O<sub>2</sub> for 1&#x202F;h to construct oxidative-inflammation model cell. Then, the model cells were treated with recombinant proteins of PGL, LPO, CD14 and B2M with 10&#x202F;mg/mL for 1&#x202F;h. The cell viability was determined using MTT. RAW264.7 cells were incubated with H<sub>2</sub>O<sub>2</sub> (500&#x202F;&#x03BC;M) for 1&#x202F;h, containing recombinant proteins with 10&#x202F;mg/mL for 1&#x202F;h. Hoechst33342, PI and DCFH-DA (10lM) staining were performed following Ma et al. (<xref ref-type="bibr" rid="ref31">31</xref>). All cell culture experiments were performed at 37&#x00B0;C and 5% CO<sub>2</sub> conditions. Apoptosis feature was analyzed by ImageJ. Each determination contained three biological replicates and was repeated three times.</p>
</sec>
<sec id="sec16">
<title>Statistical analysis</title>
<p>Statistical analysis was performed using GraphPad Prism 8.0.1 (GraphPad Software, San Diego, CA, United States). Data are presented as mean&#x202F;&#x00B1;&#x202F;standard deviation (SD). A one-way analysis of variance (ANOVA) followed by Tukey&#x2019;s <italic>post-hoc</italic> test was used to determine statistical significance. <italic>p</italic>-value &#x003C;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="sec17">
<title>Results</title>
<sec id="sec18">
<title>Proteomic patterns of horse milk separated with other three kinds of mammal milk</title>
<p>Horse milk is characterized as abundant content of proteins, including caseins, whey proteins and lactoferrin, which is beneficial for human health and immunity (<xref ref-type="bibr" rid="ref26">26</xref>). However, the detailed information about constitution and distribution of these proteins or other beneficial proteins among several mammal milk remains unclear. We then performed an in-depth proteome analysis on milk from healthy horse, cow, goat and camel (HW: horse milk in wellness; MW: Cow milk in wellness; GW: Goat milk in wellness, CW: camel milk in wellness) to illustrate the difference of protein composition among them. We first developed the principal component analysis of proteomic profiles in four groups. The result showed that distinct clustering of the four groups (CW, GW, HW, and MW), with PC1 and PC2 explaining 28.7 and 21.4% of the total variance, respectively, suggesting their variable proteomic compositions (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Intriguingly, we noticed that HW group was distinguished from other three groups with markedly separated distribution (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Consistently, Pearson correlation analysis displayed similar results that all samples from same group clustered together, and formed four clades including HW, MW, GW, and CW, demonstrating the credibility of data and differences among samples of four types of milk (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Further detailed representative proteins were mapped in correlation analysis and showed that there were four sets of proteins among these samples, which reached a consensus with the number of experimental groups (<xref ref-type="fig" rid="fig1">Figures 1B</xref>,<xref ref-type="fig" rid="fig1">C</xref>). The correlation analysis confirmed the significantly different compositions of proteomic profiles among four types of animal milk which in favor of next work.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption><p>Overview of proteomic profiles from four organisms. <bold>(A)</bold> Score plot of principal component analysis (PCA) of the proteome datasets. Each plots represented a sample in experiment. <bold>(B)</bold> Hierarchical clustering displayed the correlation among all samples. The samples from same organisms closely clustered together at one clade and clearly separated with other three groups of samples. <bold>(C)</bold> Correlation analysis among all proteins in the proteomic profiles. Red and blue represented the high and low correlation relationship between two proteins, respectively. <bold>(D)</bold> Volcano plot (<italic>p</italic>-value versus fold change ratio) displayed the significantly differentially expressed proteins in each comparison (HW vs. CW, HW vs. GW and HW vs. MW). Red dots are significant at <italic>p</italic>-value &#x003C;0.05.</p></caption>
<graphic xlink:href="fnut-12-1512669-g001.tif"/>
</fig>
<p>Subsequently, we set threshold <italic>p</italic>-value &#x003C;0.05 and |Log<sub>2</sub>foldchange|&#x202F;&#x003E;&#x202F;1.0 to identified differentially expressed proteins. In HW vs. CW comparison, 34 proteins were identified to upregulate in HW, while 89 proteins were downregulated in HW (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). In parallel, there are 53 upregulated and 68 downregulated proteins in HW vs. GW comparison (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Then, compared with MW, the expression levels of 41 proteins were higher in HW, whereas the levels of 73 proteins were lower in HW (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). And these proteins will be recognized as focus for further analysis to explain the advantages of horse milk in consumption.</p>
</sec>
<sec id="sec19">
<title>The protein component and function analysis between horse milk and cow milk</title>
<p>Horse milk is considered to be a promising alternative for cow milk, to investigate the difference of protein constitution between them, we performed Gene ontology analysis on the differentially expressed proteins in HW vs. MW. GO analysis provides a dynamically updating controlled vocabulary set to describe genes and gene product attributes in an organism. Previous identification of 69 up-regulated and 72 down-regulated proteins (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) were mapped into GO enrichment analysis. The result showed that these proteins were mainly enriched in 121 GO terms containing 96 BP terms, 9 CC terms and 16 MF terms. For terms of BP, we found that these proteins involving in protein proteolysis, peptidase activity, acute-phase response, hydrolase activity, regulation of proteolysis, regulation of endopeptidase activity, regulation of peptidase activity and catalytic activity were significantly enriched (<italic>p</italic> &#x003C; 0.05) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This implied that the proteins relevant to proteolysis activity were more active in horse milk compared to cow milk, which caused the difference of digestive absorption between them. For terms of MF, we found these proteins were predominantly gathered in odorant binding, peptidase inhibitor activity, peptidase regulator activity, endopeptidase inhibitor activity, enzyme inhibitor activity, endopeptidase regulator activity, vitamin D binding, serine-type endopeptidase inhibitor activity, molecular function regulator, transporter activity, enzyme regulator activity, calcidiol binding, pheromone binding, D<sub>3</sub> vitamins binding, vitamin binding and lipid binding (<italic>p</italic>&#x003C; 0.05) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). These results suggested that proteins associated protein degradation and activity varied between horse milk and MM, suggesting the advantages of horse milk may contained more proteins related to degradation. For terms of CC, we found these proteins were mainly enriched in organelle outer membrane, chromaffin granule, mitochondrial outer membrane, outer membrane, extracellular membrane-bounded organelle, mitochondrial membrane, mitochondrial envelope, apical dendrite and mitochondrial part (<italic>p</italic> &#x003C; 0.05) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The results suggested the location of these proteins which function proteolysis and enzyme activity. We thus proposed that HW was rich in proteins functioning active proteolysis, degradation and catalysis compared to MW, which may contribute to absorbable and palatable feature of horse milk. As expected, expression pattern of these proteins with up-regulation (foldchange&#x003E;2 in HW vs. MW) was further abstracted in proteome file and depicted in heatmap (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), showing most of proteins were from whey proteins including lactotransferrin, lysozyme C, lactoglobulin, immunoglobulin, macroglobulin, serum albumin and serotransferrin, which showed significant increase in content compared to MW. These results supported that horse milk contained more whey protein components that were easier to digest and absorb, and these whey proteins also showed beneficial goodness to human health and immunity.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption><p>GO and KEGG enrichment analysis illustrated difference of protein function between horse milk and cow milk. <bold>(A)</bold> GO enrichment analysis on differentially expressed proteins in HW vs. MW. Three main terms represented by molecular function, cellular component and biological process were shown the histogram. <bold>(B)</bold> Heatmap displayed the relative expression levels of proteins in HW and MW. The up- and downregulated proteins were shown in red and blue, respectively. The scale represented the normalized expression values of each protein. <bold>(C)</bold> KEGG enrichment analysis on differentially expressed proteins in HW vs. MW. <bold>(D)</bold> The construction of protein&#x2013;protein interaction network for differentially expressed proteins in HW vs. MW.</p></caption>
<graphic xlink:href="fnut-12-1512669-g002.tif"/>
</fig>
<p>Further KEGG enrichment pathway analysis was used to determine protein distribution in metabolic pathway. We noticed that several DEPs were significantly enriched in immune signaling pathways or disease resistance pathways (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Especially seven significantly enriched metabolic pathways including PI3K-Akt signaling pathway, MAPK signaling pathway, shigellosis, salmonella infection, <italic>Escherichia coli</italic> infection, legionellosis and endocytosis overrepresented the metabolic direction of most proteins (<italic>p</italic> &#x003C; 0.05) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; <xref rid="SM1" ref-type="supplementary-material">Supplementary Table S2</xref>). These results suggested that horse milk contained more abundant proteins potentially related to immune regulation that may contribute to trigger immune signaling pathways or reduce the risk for contaminates by such pathogenic microbes in horse milk. Additionally, these proteins were further used to construct protein&#x2013;protein interaction network, the result showed that four hub proteins like HSP90AA1, YWHAE, APOE, and ENO1 functioned pivotal roles in regulation of immune regulatory network in horse milk (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Studies have shown that these proteins functioned as modulators in the regulation of NF-&#x03BA;B and MPK signaling pathways, contributing to host defense against pathogen infections (<xref ref-type="bibr" rid="ref32">32</xref>&#x2013;<xref ref-type="bibr" rid="ref34">34</xref>). Therefore, our findings demonstrated that HW had advantages on elevated accumulation of whey proteins and immune-related proteins for human health and immunity compared to MW.</p>
</sec>
<sec id="sec20">
<title>The protein component and function analysis between horse milk and goat milk</title>
<p>In the comparison of HW vs. GW, 108 up-regulated proteins and 114 down-regulated DEPs were into GO enrichment analysis and found that these proteins were mainly enriched in 275 GO terms containing 230 BP terms, 9 CC terms and 36 MF terms. For terms of BP, we found that these proteins were remarkably clustered in BP term of the negative regulation of catalytic activity (<italic>p</italic> &#x003C; 0.01, FDR&#x202F;&#x003C;&#x202F;0.05) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Besides, we also noticed that proteins related to negative regulation of catalytic activity, negative regulation of molecular function and inflammatory response were significantly enriched (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The results implied that significant difference of protein components between both types of milk proteins was the variation of catalytic activity which may account for different nutrition constitution and flavor between them. For terms of MF, we found these proteins were predominantly gathered in enzyme inhibitor activity, endopeptidase inhibitor activity, molecular function regulator, endopeptidase regulator activity, peptidase inhibitor activity and enzyme regulator activity (<italic>p</italic> &#x003C; 0.05, FDR&#x202F;&#x003C;&#x202F;0.1) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The result showed that proteins associated protein degradation and activity were significantly enriched in HW compared to GW, suggesting more active protein degradation and digestion events occurred in HW. Indeed, low molecular weight protein in milk composition was readily available to assimilation for human. We thus proposed their difference of absorption should be taken into consideration in further assessment between them. For terms of CC, we found these proteins were predominantly enriched in blood microparticle, nuclear outer membrane, high-density lipoprotein particle, basolateral plasma membrane, cell surface, nuclear envelope lumen, HFE-transferrin receptor complex, nuclear chromatin and phagocytic cup (<italic>p</italic> &#x003C; 0.05) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). The results suggested the location of these proteins which function regulator or enzyme activity. Expression of these proteins were further depicted in heatmap (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), illustrating that most of whey protein components were up-regulated in HW compared to GW, leading to the higher benefits for human health and immunity.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption><p>GO and KEGG enrichment analysis illustrated difference of protein function between horse milk and goat milk. <bold>(A)</bold> GO enrichment analysis on differentially expressed proteins in HW vs. GW. Three main terms represented by molecular function, cellular component and biological process were shown the histogram. <bold>(B)</bold> Heatmap displayed the relative expression levels of proteins in HW and GW. The up- and downregulated proteins were shown in red and blue, respectively. The scale represented the normalized expression values of each protein. <bold>(C)</bold> KEGG enrichment analysis on differentially expressed proteins in HW vs. GW. <bold>(D)</bold> the construction of protein&#x2013;protein interaction network for differentially expressed proteins in HW vs. GW.</p></caption>
<graphic xlink:href="fnut-12-1512669-g003.tif"/>
</fig>
<p>Based on previous result, 108 up-regulated proteins and 114 down-regulated proteins were further mapped into KEGG enrichment pathway analysis in the comparison of HW vs. GW. The results showed that the DEPs linked in such immune signaling pathways representing main function of them, including PPAR signaling pathway, HIF-1 signaling pathway, ferroptosis, ECM-receptor interaction and complement and coagulation cascades were significantly enriched (<xref rid="SM1" ref-type="supplementary-material">Supplementary Table S3</xref>). PPAR (peroxisome proliferators-activated receptor) signaling pathway partook in the physiological processes of lipid metabolism, cell proliferation and differentiation (<xref ref-type="bibr" rid="ref35">35</xref>). HIF-1 (hypoxia- inducible factor-1) signaling pathways promote the adaption to low oxygen tension in cells and organisms resulting in the transcriptional induction of a series of genes that participate in angiogenesis, iron metabolism, glucose metabolism, and cell proliferation/survival (<xref ref-type="bibr" rid="ref36">36</xref>). It has been reported that the higher accumulation of proteins relevant to PPAR, HIF-1 signaling pathways and ferroptosis enhanced the risk of inflammatory bowel disease (<xref ref-type="bibr" rid="ref37">37</xref>, <xref ref-type="bibr" rid="ref38">38</xref>). Thus, these results suggested that HW could avoid to stimulate organic inflammatory response and reduce the risk of pathogenic microbes compared to GW. Meanwhile, most of proteins were gathered in such metabolic pathways, including phagosome, proteoglycans in cancer, regulation of actin cytoskeleton, tuberculosis pathogenic <italic>E. coli</italic> infection and MAPK signaling pathway (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). We noticed that these enriched proteins probably functioned as antibodies associated with the pathogenic bacterium species like shigellosis, salmonella and <italic>E. coli</italic> that mainly caused bowel diseases. it was documented that horse milk exhibited the inhibitory effect to <italic>Salmonella Typhimurium</italic> by suppressing the virulence gene expression (<italic>hilA</italic> and <italic>ssrB</italic>2) (<xref ref-type="bibr" rid="ref39">39</xref>). Moreover, donkey belonged to Equus genus, was found to contained many antimicrobial factors by proteomic analysis, implying the antimicrobial activity of donkey&#x2019;s milk (<xref ref-type="bibr" rid="ref40">40</xref>). We thus speculated that HW may contain some immune related proteins that exerted the positive therapy effect to multiple disease compared to GM. Further construction of protein interaction network showed five hub immune-related proteins such as HSP90AA1, ACTB, APOE, APP, and EGFR functioned crucial roles in manipulation of host immune response in horse milk (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), which may take part in prevention of pathogenic microbes or immune trigger in horse milk.</p>
</sec>
<sec id="sec21">
<title>The protein component and function analysis between horse milk and camel milk</title>
<p>For differentially expressed proteins in HW vs. CW comparison, GO functional enrichment analysis was performed on all 34 upregulated and 89 downregulated proteins (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The results cover a wide range of terms relevant to molecular functions (MF), biological processes (BP) and cellular components (CC). There are 84 terms with <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 were significantly enriched against these 123 differentially expressed proteins (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). For terms of cellular component (CC), these proteins mainly performed functions at high-density lipoprotein particle, postsynaptic specialization, neuron to neuron synapse, postsynaptic density, asymmetric synapse, protein-lipid complex, plasma lipoprotein particle, lipoprotein particle, preribosome, membrane microdomain and membrane raft (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). And these proteins mainly performed seven kinds of functions, including transferase activity, transferring aldehyde or ketonic groups, lipid binding, ATPase regulator activity, high-density lipoprotein particle binding, molecular function regulator, enzyme regulator activity and ATPase binding, implying their importance in nutritional support and bioavailability of nutrients in horse milk (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Additionally, for biological process category (BP), 66 related terms were significantly overrepresented among these proteins, including cellular copper ion, homeostasis, copper ion homeostasis, striated muscle adaptation, amyloid fibril formation, positive regulation of hemostasis, positive regulation of coagulation, positive regulation of blood coagulation, glyceraldehyde-3-phosphate metabolic process, glucose 6-phosphate metabolic process, pentose-phosphate shunt, muscle atrophy, striated muscle atrophy, sterol transport, cholesterol transport, regulation of lipid catabolic process, positive regulation of lipid catabolic process, regulation of cytokine production involved in immune response, protein kinase A signaling, muscle adaptation and negative regulation of fibrinolysis (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Previous studies mentioned the benefits of horse milk for contributing to homeostasis and bone development, and we noticed that the enrichment of several proteins was closely associated with positive regulation of hemostasis, muscle atrophy and striated muscle atrophy, implying that horse milk exhibited a potential therapy effect to bone disease (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Meanwhile, various proteins involved in primary metabolisms were enriched, such as regulation of lipid catabolic process, glyceraldehyde-3-phosphate and cholesterol transport (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Heatmap illustrated expression level of these associated proteins showing most of them belonged to whey protein components with significant up-regulation in HW compared to CW (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). These results suggested the advantages of horse milk in improving immunity and chemicals which could be used as energy and nutrient for human, compared with CW.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption><p>GO and KEGG enrichment analysis illustrated difference of protein function between horse milk and camel milk. <bold>(A)</bold> GO enrichment analysis on differentially expressed proteins in HW vs. CW. Three main terms represented by molecular function, cellular component and biological process were shown the histogram. <bold>(B)</bold> Heatmap displayed the relative expression levels of proteins in HW and CW. The up- and downregulated proteins were shown in red and blue, respectively. The scale represented the normalized expression values of each protein. <bold>(C)</bold> KEGG enrichment analysis on differentially expressed proteins in HW vs. CW. <bold>(D)</bold> the construction of protein&#x2013;protein interaction network for differentially expressed proteins in HW vs. CW.</p></caption>
<graphic xlink:href="fnut-12-1512669-g004.tif"/>
</fig>
<p>Further pathway enrichment analysis on these proteins showed that they were mapped onto 144 KEGG pathway, with 5 pathways were significantly enriched against these proteins, including phagosome, PI3K-Akt signaling pathway, pathways in cancer, rap1 signaling pathway, MAPK signaling pathway and pathogenic <italic>Escherichia coli</italic> infection (<xref ref-type="fig" rid="fig4">Figure 4C</xref>; <xref rid="SM1" ref-type="supplementary-material">Supplementary Table S4</xref>). Further construction of protein interaction network showed potential interacted and regulatory relationship among them, we noticed six hub proteins including HSP90AA1, EEF2, ACTG1, ACTB, YWHAE, PFN1, and HSPAB functioned essential roles in regulation of these proteins in immune response (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These proteins may act as triggers or antigens in response to pathogenic microbes&#x2019; invasion.</p>
</sec>
<sec id="sec22">
<title>Increased accumulation of immune-related proteins in horse milk conferred more healthy benefits</title>
<p>To identified the hub proteins that highly expressed in HW compared to other three organisms, we analyzed all upregulated proteins in HW vs. CW, HW vs. GW and HW vs. MW comparisons (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). As shown in <xref ref-type="fig" rid="fig5">Figure 5A</xref>, we identified 32 candidate proteins shared in at least two comparisons. Remarkably, in total 7 proteins were shared in three comparisons, suggesting their levels were significantly higher in HW than other three organisms (<xref ref-type="fig" rid="fig5">Figures 5A</xref>,<xref ref-type="fig" rid="fig5">B</xref>). Then, we analyzed the expression levels of all 32 proteins among all samples, and identified 15 proteins that highly expressed in HW than other three organisms (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). These 15 proteins were recognized as hub proteins which contributed to the advantages of horse milk. Especially four whey protein components including <italic>&#x03B1;</italic>-lactalbumin (XP_001915824), lysozyme C (XP_001491556), <italic>&#x03B2;</italic>-lactoglobulin-1 precursor (NP_001075962) and lactotransferrin precursor (NP_001157446) showed significant accumulation in HW compared to other three types of milk.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption><p>identification and function enrichment analysis on hub upregulated proteins in HW. <bold>(A)</bold> Upset diagrams representing the overlap of significantly upregulated proteins in HW vs. CW, HW vs. GW and HW vs. MW pairwise comparisons. The hub upregulated proteins of HW were labeled by purple. <bold>(B)</bold> Clustering analysis of hub upregulated proteins in HW. The proteins with relative high expression level were shown in red, whereas the relative low expression level was shown in white. <bold>(C)</bold> KEGG pathway classification of hub upregulated proteins.</p></caption>
<graphic xlink:href="fnut-12-1512669-g005.tif"/>
</fig>
<p>The pathway enrichment analysis is the most intuitive way to understand the advantages of horse milk, thus KEGG pathway enrichment analysis was employed to reveal the functional roles of these 15 hub proteins (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The results showed the overrepresentation of 20 pathways among these 15 hub proteins associated with HW, including prolactin signaling pathway, HIF-1 signaling pathway, intestinal immune network for IgA production, Complement and coagulation cascades, RNA degradation, SNARE interactions in vesicular transport, caffeine metabolism, thyroid hormone synthesis, pertussis and drug metabolism (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). IgA has been implicated in functioning center roles in the maintain of normal development and suppressing harmful bacterial microbes (<xref ref-type="bibr" rid="ref9">9</xref>). We noted various pathways relevant to immunity were identified, including HIF-1 signaling pathway, Intestinal immune network for IgA production and complement and coagulation cascades (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), suggesting that usage of horse milk could improve human immunity. Additionally, various metabolisms relevant to beneficial chemicals were found to be active in HW, like amino acids and glycolysis/gluconeogenesis (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), indicating that horse milk is rich in these related proteins.</p>
</sec>
<sec id="sec23">
<title>The identification of antimicrobial associated proteins in horse milk</title>
<p>To further investigate the molecular function of these seven shared proteins with high expression in horse milk, we examined the expression profiles and listed them in <xref ref-type="table" rid="tab1">Table 1</xref>, including LPO, B2M, NAMLAA, CD14, TLR2, PG4, and LTFp. Notably, we found that the expression of LPO, B2M, NAMLAA, and CD14 was significantly increased in three pairwise comparisons, suggesting the four candidate proteins may confer strong antimicrobial activity in horse milk.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption><p>The expression profiles of unique antimicrobial associated proteins in HW.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">NCBI ID</th>
<th align="left" valign="top">Annotation</th>
<th align="left" valign="top">Abbreviation</th>
<th align="center" valign="top">Log<sub>2</sub>FC (HW/CW)</th>
<th align="center" valign="top">Log<sub>2</sub>FC (HW/GW)</th>
<th align="center" valign="top">Log<sub>2</sub>FC (HW/MW)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">XP_014596904.2</td>
<td align="left" valign="middle">Lactoperoxidase</td>
<td align="left" valign="middle">LPO</td>
<td align="center" valign="middle">1.33&#x002A;&#x002A;</td>
<td align="center" valign="middle">1.91&#x002A;&#x002A;</td>
<td align="center" valign="middle">1.42&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="middle">XP_005602652.1</td>
<td align="left" valign="middle">Beta-2-microglobulin</td>
<td align="left" valign="middle">B2M</td>
<td align="center" valign="middle">1.21&#x002A;&#x002A;</td>
<td align="center" valign="middle">1.51&#x002A;&#x002A;</td>
<td align="center" valign="middle">1.32&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="middle">XP_023481087.1</td>
<td align="left" valign="middle">N-acetylmuramoyl-L-alanine amidase</td>
<td align="left" valign="middle">NAMLAA<break/>(PGL)</td>
<td align="center" valign="middle">1.25&#x002A;&#x002A;</td>
<td align="center" valign="middle">1.1&#x002A;</td>
<td align="center" valign="middle">1.21&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="middle">XP_023490830.1</td>
<td align="left" valign="middle">Monocyte differentiation antigen CD14</td>
<td align="left" valign="middle">CD14</td>
<td align="center" valign="middle">1.52&#x002A;&#x002A;</td>
<td align="center" valign="middle">1.08&#x002A;</td>
<td align="center" valign="middle">1.18&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="middle">XP_023481835.1</td>
<td align="left" valign="middle">Toll-like receptor 2</td>
<td align="left" valign="middle">TLR2</td>
<td align="center" valign="middle">0.88</td>
<td align="center" valign="middle">1.01&#x002A;</td>
<td align="center" valign="middle">1.21&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="middle">XP_023494587.1</td>
<td align="left" valign="middle">Platelet glycoprotein 4</td>
<td align="left" valign="middle">PG4</td>
<td align="center" valign="middle">0.74</td>
<td align="center" valign="middle">0.87</td>
<td align="center" valign="middle">1.19&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="middle">NP_001157446.1</td>
<td align="left" valign="middle">Lactotransferrin precursor</td>
<td align="left" valign="middle">LTFp</td>
<td align="center" valign="middle">0.84</td>
<td align="center" valign="middle">1.01&#x002A;&#x002A;</td>
<td align="center" valign="middle">1.34&#x002A;&#x002A;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>&#x002A;P</italic>&#x202F;&#x003C;&#x202F;0.05, <italic>&#x002A;&#x002A;p</italic>&#x202F;&#x003C;&#x202F;0.01.</p>
</table-wrap-foot>
</table-wrap>
<p>To explore the sequence characterization of these candidate proteins, a phylogenetic tree was constructed to evaluate their evolutionary relationships. As shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>, we found that LPO was clustered with its homologous protein derived from <italic>Equus caballus</italic>, <italic>Sus scrofa</italic>, <italic>Equus asinus</italic>, and <italic>Diceros bicornis</italic>. NAMLAA (PGL) had an aggregation with proteins coming from <italic>Equus quagga</italic> and <italic>Equus asinus</italic>. CD14 had a high sequence conservation in multiple horse species including <italic>Equus caballus</italic>, <italic>Equus asinus</italic>, and <italic>Equus quagga</italic>. And Equus-derived B2M proteins were also closely gathered in one clade. In common, the candidate proteins were sequence-conservative in Equus genus, suggesting their conservative molecular function in horse milk.</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption><p>Phylogenetic tree of candidate proteins in horse milk.</p></caption>
<graphic xlink:href="fnut-12-1512669-g006.tif"/>
</fig>
<p>Based on AlphaFold protein structure database<xref ref-type="fn" rid="fn0003"><sup>3</sup></xref> (<xref ref-type="bibr" rid="ref41">41</xref>), we predicted probable protein structure of four candidate proteins, depicting them as <xref ref-type="fig" rid="fig7">Figure 7A</xref>. Among them, B2M protein showed relatively simple structure, containing a <italic>&#x03B1;</italic>-helix and five <italic>&#x03B2;</italic>-sheets. And these structures also could be spotted in other three proteins, which play a crucial role in maintaining protein conformation stability under various stress conditions, thereby ensuring the proper execution of its biological functions. Studies have shown that B2M played a role in regulating immune responses, antigen presentation, and immune tolerance, especially interaction with defensin protein elevating resistance to multiple pathogens invasion (<xref ref-type="bibr" rid="ref42">42</xref>). LPO is a peroxidase widely present in mammalian milk, playing a crucial role in antibacterial activity, immune regulation, and oxidative stress control (<xref ref-type="bibr" rid="ref43">43</xref>). PGL is a class of enzymes involved in bacterial cell wall degradation, contributing to cell wall metabolism, bacteriolysis, and host immune defense (<xref ref-type="bibr" rid="ref44">44</xref>). CD14 activates innate immunity and enhances downstream antimicrobial components, including LPO and lysozyme, to protect against pathogenic infections (<xref ref-type="bibr" rid="ref45">45</xref>). We then performed codon optimization of NAMLAA (PGL), CD14, and LPO for next protein purification. The optimized open reading frame (ORF) of candidate proteins was cloned and fused with pGEX-4&#x202F;T-1 for prokaryotic expression. Further SDS-PAGE and Western Blot assays authorized the successful expression of four candidate proteins (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Purified proteins fused with GST tag were lyophilized to condense at the concentration of 10&#x202F;mg/mL. We then performed an <italic>in vitro</italic> antimicrobial activity assay to assess the capacity of inhibition against multiple pathogenic microorganisms. In total, four bacterial strains including <italic>Pseudomonas aeruginosa</italic>, <italic>Staphylococcus aureus</italic>, <italic>Escherichia coli</italic>, and <italic>Staphylococcus epidermidis</italic> were chose for testing object. As shown in <xref ref-type="fig" rid="fig7">Figure 7C</xref>, exogenous application of PGL and LPO showed marked inhibition to <italic>P. aeruginosa</italic> growth (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). In anti-<italic>Escherichia coli</italic> assay, only application of PGL could inhibit pathogen growth (<xref ref-type="fig" rid="fig7">Figures 7C</xref>,<xref ref-type="fig" rid="fig7">D</xref>). None of the tested antimicrobial proteins exhibited significant inhibitory effects against <italic>S. epidermidis</italic> and <italic>S. aureus</italic> (<xref ref-type="fig" rid="fig7">Figures 7C</xref>,<xref ref-type="fig" rid="fig7">D</xref>). Overall, our results suggested that the usage of horse milk improved human immunity attributing to abundant accumulation of proteins with direct antimicrobial activity.</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption><p>Candidate proteins in HW conferred antimicrobial activity for multiple pathogenetic microorganisms. <bold>(A)</bold> The probable protein structure model predicted by AlphaFold database. <bold>(B)</bold> The authorization of SDS-PAGE and Western Blot for expression of candidate proteins. <bold>(C)</bold> <italic>In vitro</italic> antimicrobial activity assay tested the inhibition effect of candidate proteins responding to multiple microorganisms. The inhibitory effect of these pathogens was evaluated by paper disk method. GST protein was used as negative control and ampicillin sodium with the concentration of 50&#x202F;&#x03BC;g/mL was used as positive control. Scale bar is 2&#x202F;cm. <bold>(D)</bold> The assessment of inhibitory effectiveness of candidate proteins. Effectiveness was evaluated by subtracting the paper disc diameter from the inhibition zone diameter.</p></caption>
<graphic xlink:href="fnut-12-1512669-g007.tif"/>
</fig>
</sec>
<sec id="sec24">
<title>Elevated immunity in horse milk by four antimicrobial proteins</title>
<p>To further evaluate the resistant contributions of four antimicrobial protein in immunity, we exogenously treated RAW264.7 cells with four antimicrobial proteins. First, we examined the toxicity of four proteins on RAW264.7 cells. The results showed that exogenous treatment with antibacterial proteins at 5&#x2013;20&#x202F;mg/mL did not significantly inhibit cell viability, ensuring that none of the four antibacterial proteins were toxic to RAW264.7 cells (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure S1</xref>). H<sub>2</sub>O<sub>2</sub> is a well-recognized inducer of apoptosis. Our research discovered that pre-treatment with the four antibacterial proteins reduced H<sub>2</sub>O<sub>2</sub>-induced apoptosis in RAW264.7 cells, with CD14 and PGL demonstrating significant inhibitory effects (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure S1</xref>). Further electron microscopy observation showed that PGL and CD14 proteins could inhibit H<sub>2</sub>O<sub>2</sub>-induced apoptosis, significantly reducing the apoptosis rate by approximately 25~30% (<xref ref-type="fig" rid="fig8">Figures 8A</xref>,<xref ref-type="fig" rid="fig8">B</xref>). This supports the notion that PGL and CD14 proteins possess anti-apoptotic activity in RAW264.7 cells. To further investigate the immune effects of the core proteins LPO, PGL, CD14, and B2M on their host, we treated RAW264.7 cells with the core proteins LPO, PGL, CD14, and B2M, along with H<sub>2</sub>O<sub>2</sub>, for 1&#x202F;h. Samples were collected for RNA extraction and reverse transcription into cDNA. qRT-PCR was then used to measure the relative expression levels of immune-related genes <italic>AKT</italic>, <italic>BCL2</italic>, <italic>FOS</italic>, <italic>IL17</italic>, <italic>IL6</italic>, <italic>JAK2</italic>, <italic>NR3C1</italic>, <italic>PI3K</italic>, and <italic>TNFa</italic> (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). These genes were relatively upregulated in RAW264.7 cells treated with H<sub>2</sub>O<sub>2</sub>. Importantly, <italic>CD14</italic> and <italic>PGL</italic> notably induced the upregulation of immune-related genes, excluding <italic>TNFa</italic>, thereby enhancing the immune response in RAW264.7 cells.</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption><p>Exogenous application of CD14 and PGL inhibited apoptosis and enhanced host immunity. <bold>(A)</bold> The apoptosis of horse milk treated with PGL and CD14 protein and hydrogen peroxide was observed, scale bar is 50&#x202F;&#x03BC;M. <bold>(B)</bold> Cell apoptosis statistics between treatments. Different letters represent significant differences between treatments. <bold>(C)</bold> The relative expression levels of immune-related genes in H202, LPO, PGL, CD14, and B2M treated horse milk were detected by RT-qPCR. Normal indicates normalization. The relative expression levels of immune-related genes in LPO, PGL, CD14, and B2M treated horse milk were detected by RT-qPCR, normal indicates normalization. Error bars represent the standard deviation of the means. Different letters represent significant differences between treatments.</p></caption>
<graphic xlink:href="fnut-12-1512669-g008.tif"/>
</fig>
</sec>
<sec id="sec25">
<title>Exogenous treatment of PGL inhibited pathogen growth by interference of secondary metabolism</title>
<p>Through scanning electron microscopy, we directly observed that PGL exogenous treatment for 30&#x202F;min caused damage to the cell membrane structure of <italic>Escherichia coli</italic> and <italic>Pseudomonas aeruginosa</italic> (<xref ref-type="fig" rid="fig9">Figures 9A</xref>,<xref ref-type="fig" rid="fig9">D</xref>). However, the molecular mechanism by which it induces host immunity is still unclear. Therefore, we continued to explore the transcriptional changes in these two bacteria under PGL treatment by transcriptome analysis. First, PCA analysis revealed significant transcriptional changes in <italic>E. coli</italic> and <italic>P. aeruginosa</italic> after PGL treatment, resulting in 80.71 and 66.29% of transcriptomic differences, respectively (<xref ref-type="fig" rid="fig9">Figures 9B</xref>,<xref ref-type="fig" rid="fig9">E</xref>). This supports that PGL treatment caused major transcriptional changes in these bacteria. Volcano plots showed that, compared with the control, PGL treatment resulted in 258 upregulated and 392 downregulated differentially expressed genes in <italic>E. coli</italic>, and 825 upregulated and 954 downregulated differentially expressed genes in <italic>P. aeruginosa</italic> (<xref ref-type="fig" rid="fig9">Figures 9C</xref>,<xref ref-type="fig" rid="fig9">F</xref>). These differentially expressed genes were mapped to specific functional blocks through further GO and KEGG enrichment analysis, reflecting the transcriptional changes induced by PGL in host immunity.</p>
<fig position="float" id="fig9">
<label>Figure 9</label>
<caption><p>A global view of transcriptome files of <italic>Escherichia coli</italic> and <italic>Pseudomonas aeruginosa</italic> treated by PGL. <bold>(A,D)</bold> Observations of the morphology of <italic>E. coli</italic> and <italic>P. aeruginosa</italic> after 30&#x202F;min of PGL protein treatment under scanning electron microscopy. The left image shows the normal morphology of normal pathogens (&#x00D7;12,000), while the right image shows the morphology of pathogens (&#x00D7;12,000) after 30&#x202F;min of protein PGL treatment. Scale bar is 1&#x202F;&#x03BC;m. <bold>(B,E)</bold> Principal component analysis of transcriptome files of <italic>Escherichia coli</italic> and <italic>Pseudomonas aeruginosa</italic> treated by PGL as well as controls. <bold>(C,F)</bold> Identification of differentially expressed genes (DEGs) in PE vs. CK-E and PP vs. CK-P using volcano plots.</p></caption>
<graphic xlink:href="fnut-12-1512669-g009.tif"/>
</fig>
<p>Secondly, GO enrichment analysis indicated that the differentially expressed genes in <italic>E. coli</italic> were mainly distributed in biological process categories, with upregulated genes significantly enriched in intracellular biomolecule synthesis and downregulated genes mainly associated with transmembrane and localization (<xref ref-type="fig" rid="fig10">Figure 10A</xref>). These results suggest that PGL may interfere with the synthesis and transport of intracellular biomolecules, thereby affecting the growth of <italic>E. coli</italic>. In <italic>P. aeruginosa</italic>, the upregulated differentially expressed genes were predominantly enriched in cell metabolism and catalytic activity categories, while the downregulated genes were mainly related to intracellular components and membrane components (<xref ref-type="fig" rid="fig10">Figure 10B</xref>). This indicates that PGL might disrupt normal catalytic processes, affecting the integrity of intracellular components.</p>
<fig position="float" id="fig10">
<label>Figure 10</label>
<caption><p>GO enrichment analysis illustrated the functional distribution of differentially expressed genes in PE vs. CK-E and PP vs. CK-P. <bold>(A)</bold> GO enrichment analysis of up-regulated and down-regulated DEGs in PE vs. CK-E. <bold>(B)</bold> GO enrichment analysis of up-regulated and down-regulated DEGs in PP vs. CK-P.</p></caption>
<graphic xlink:href="fnut-12-1512669-g010.tif"/>
</fig>
<p>KEGG analysis revealed that the differentially expressed genes in <italic>E. coli</italic> were primarily enriched in pathways including oxidative phosphorylation, metabolic pathways, carbon metabolism, and biosynthesis of antibiotics. Notably, there was a majority of downregulated genes in pathways related to metabolism and antibody synthesis. These findings indicate that PGL inhibits metabolic processes and antibiotic synthesis in <italic>E. coli</italic>, leading to the suppression of pathogenic bacterial growth (<xref ref-type="fig" rid="fig11">Figure 11A</xref>). In <italic>P. aeruginosa</italic>, differentially expressed genes were significantly enriched in pathways related to biosynthesis of secondary metabolite, biosynthesis of amino acids and carbon metabolism, suggesting that PGL exogenous treatment disrupted the normal pathways of secondary metabolite synthesis, leading to inhibition of pathogenic bacterial growth (<xref ref-type="fig" rid="fig11">Figure 11B</xref>). In summary, these findings indicate that PGL suppresses the growth of pathogenic bacteria by disrupting the synthesis of secondary metabolites.</p>
<fig position="float" id="fig11">
<label>Figure 11</label>
<caption><p>KEGG enrichment analysis illustrated the metabolic pathways of differentially expressed genes in PE vs. CK-E and PP vs. CK-P. <bold>(A)</bold> KEGG enrichment analysis of DEGs in PE vs. CK-E. <bold>(B)</bold> KEGG enrichment analysis of DEGs in PP vs. CK-P.</p></caption>
<graphic xlink:href="fnut-12-1512669-g011.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec26">
<title>Discussion</title>
<p>Researches on more nutritious and affordable milk source are of paramount importance. This study investigated the changes in protein and metabolites abundance in cow, goat, camel and horse milk by proteomic analysis. We summarized our acquired evidence depicting them as following conclusions. (a) Horse milk varied from other types of milk (cow, goat and camel) in protein composition. (b) Horse milk contained proteins distinguished from others with readily available for proteolysis, absorption and human immunity. (c) The increased content of proteins in horse milk contributed to elevate immune response and resistance to pathogenic disease. (d) The Identification of PGL protein conferred inhibitory effects to <italic>Escherichia coli</italic> and <italic>Pseudomonas aeruginosa</italic> by repressing biosynthesis of secondary metabolites.</p>
<p>Despite the low yield of horse milk because of lactation and longer gestation, its nutritional value was emphasized due to abundant whey protein and microelements (<xref ref-type="bibr" rid="ref46">46</xref>). Our data verified that whey proteins occupied the most proportion in total proteins of horse milk among these four types of animal milk. Whey proteins were not only readily to digest and absorb, but also contained various amino acids that are essential for human, like lysine (Lys), leucine (Leu), glutamic acid (Glu), and aspartic acid (Asp), which were beneficial to muscle growth, energy production and gut health (<xref ref-type="bibr" rid="ref47">47</xref>). As a comparison, cow milk contained plentiful casein proteins compared to whey proteins (casein: whey =4: 1), especially A1-<italic>&#x03B2;</italic> casein, which has been reported to be directly associated with milk intolerance (<xref ref-type="bibr" rid="ref48">48</xref>). Huge demands for cow milk around the world, though there still cannot be neglected the cow milk intolerance. Our data highlighted the advantage of whey protein in horse milk, and proteomic analysis showed that horse milk contained more abundant proteins relevant to proteolysis, degradation and catalysis, suggesting the potential benefits of horse milk in absorption and palatability. Like casein proteins with large molecular weight were uneasy to degrade, which could be decomposed into small casein peptides by caseinase in milk (<xref ref-type="bibr" rid="ref49">49</xref>). Besides, active proteins related to caffeine metabolism, biosynthesis of amino acids and glycolysis/gluconeogenesis in horse milk suggested potential contributions to flavor and taste of horse milk. Despite these advantages, positioning horse milk as an easily assimilated dietary alternative, several challenges limit its widespread production and consumption. Its lower protein and fat content may limit its nutritional appeal, while high lactose levels pose concerns for lactose-intolerant individuals (<xref ref-type="bibr" rid="ref50">50</xref>). Production constraints, including low yield and seasonal lactation, restrict large-scale commercialization. Additionally, storage stability, microbial susceptibility, and optimal pasteurization require further investigation (<xref ref-type="bibr" rid="ref46">46</xref>). Future research should focus on enhancing preservation strategies, refining processing techniques, and exploring its immunomodulatory and antimicrobial potential to expand its applications in health and nutrition.</p>
<p>In recent years, increasing interests has been taken in the immunomodulatory properties of dairy products, especially for immune function and modulating immune responses. Our data suggested a promising application of horse milk on therapy effect to multiple human diseases. Proteomic analysis indicated that proteins relevant to shigellosis, salmonella infection, <italic>E. coli</italic> infection, tuberculosis and thyroid cancer were highly enriched in horse milk compared to other types of milk (cow, goat and camel milk). Intriguingly, many proteins in horse milk were remarkably enriched in immune pathways, such as PI3K-Akt, Rap1, PPAR, and MAPK signaling pathways, which has been emphasized in many documents as essential hub governor to modulate apoptosis, inflammation and immunity events in organic development (<xref ref-type="bibr" rid="ref51">51</xref>). These results suggested potential immune benefits of horse milk.</p>
<p>The functional characterization of antimicrobial proteins in horse milk provides critical insights into its quality, bioactivity, and unique properties. As an underexplored dairy source, horse milk harbors a diverse repertoire of bioactive proteins with potential roles in host defense, microbial balance, and immune modulation. Our identification of antimicrobial components in horse milk contributed to advances our understanding of horse milk&#x2019;s functional attributes but also paves the way for its broader application in nutrition and health. Donkey belonged to Equus genus, previous studies demonstrated that donkey&#x2019;s milk contained many antimicrobial factors with inhibitory effect (<xref ref-type="bibr" rid="ref40">40</xref>). Our identification of PGL and LPO with conservative evolutionary relationships in Equus genus, which conferred direct antimicrobial activity to inhibit the growth of <italic>P. aeruginosa</italic> and <italic>E. coli</italic>. Consistent with our finding, Guri et al. (<xref ref-type="bibr" rid="ref39">39</xref>) manifested that some active antibacterial proteins existed in horse milk that resulted in an inhibitory effect to <italic>Salmonella Typhimurium</italic> growth. <italic>&#x03B2;</italic>-defensin in human, well-known for their broad-spectrum antimicrobial activity, are key players in mucosal immunity and pathogen defense (<xref ref-type="bibr" rid="ref52">52</xref>). It has been reported that the content of lysozyme protein in horse milk was higher than that in cow and human milk, which also implied higher antimicrobial activity in horse milk due to lysozyme capability (<xref ref-type="bibr" rid="ref53">53</xref>). Besides, we speculated that natural antibacterial activity of candidate proteins could ensure horse milk to maintain a relatively long shelf life and a low rate of pathogenic contamination without excessive processing, awaiting to be further studied.</p>
<p>Despite these findings illustrated the importance of antimicrobial proteins in inhibitory effect, immune activation by them should not be ignored. Enhancement of immune resistance by horse milk diet has been reported in recent years, especially in the treatment of tuberculosis and chronic ulcer (<xref ref-type="bibr" rid="ref54">54</xref>). In this study, exogenous application of LPO, PGL, CD14, and B2M enhanced host immune response by elevating expression of immune-related genes like <italic>AKT</italic>, <italic>PI3K</italic>, <italic>IL6</italic>, <italic>IL17</italic> and so on, highlighting their contributions to host immunity in horse milk. Among them, we identified that PGL functioned dually by direct antibacterial activity and priming immune signaling in pathogen resistance. Our transcriptome analysis demonstrated that PGL could repress transcription related to key secondary metabolism pathways in both bacterial. These pathways are crucial to produce various metabolites that contribute to the bacterial virulence and resistance mechanisms. The inhibition of these pathways by PGL suggests a disruption to bacteria&#x2019;s metabolic versatility and ability to adapt to environmental stressors. We reasoned that this disruption may exert profound implications for antimicrobial resistance (AMR), as secondary metabolites are often involved in the production of resistance factors. We proposed that further investigation into the metabolic changes induced by antimicrobial proteins like PGL could lead to innovative therapeutic interventions, providing a promising avenue for combating the growing threat of antimicrobial resistance.</p>
</sec>
<sec sec-type="conclusions" id="sec27">
<title>Conclusion</title>
<p>In this study, we highlight the unique advantages of horse milk in immune enhancement and nutrient composition, demonstrating its potential as a functional food and an alternative for individuals with cow milk allergies. Our identification of proteins (B2M, PGL, CD14, and LPO) in horse milk contributes to human immunity. Among them, PGL function triply by <italic>in vitro</italic> antibacterial activity, immune activation and interference with secondary metabolism in pathogenic bacteria. Our findings insights into comprehension of horse milk compounds and molecular immune mechanism, expecting to provide a theoretical basis for promotion of horse milk. Molecular insights into identification of bioactive compounds in horse milk provide theoretical basis for therapeutic applications, broadening the dietary and medical potential of horse milk.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec28">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article and <xref ref-type="sec" rid="sec35">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="sec29">
<title>Ethics statement</title>
<p>The manuscript presents research on animals that do not require ethical approval for their study.</p>
</sec>
<sec sec-type="author-contributions" id="sec30">
<title>Author contributions</title>
<p>XC: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. KG: Conceptualization, Validation, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. HD: Validation, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. CN: Validation, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. XG: Conceptualization, Validation, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec31">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by Key Research and Development Project of Xinjiang Uygur Autonomous Region (2024B02013).</p>
</sec>
<sec sec-type="COI-statement" id="sec32">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec33">
<title>Generative AI statement</title>
<p>The author(s) declare that no Gen AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="sec34">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec35">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fnut.2025.1512669/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnut.2025.1512669/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.zip" id="SM1" mimetype="application/zip" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<fn-group>
<fn id="fn0001"><p><sup>1</sup><ext-link xlink:href="https://www.omicstudio.cn" ext-link-type="uri">https://www.omicstudio.cn</ext-link></p></fn>
<fn id="fn0002"><p><sup>2</sup><ext-link xlink:href="http://218.2.224.234:8888" ext-link-type="uri">http://218.2.224.234:8888</ext-link></p></fn>
<fn id="fn0003"><p><sup>3</sup><ext-link xlink:href="https://alphafold.ebi.ac.uk" ext-link-type="uri">https://alphafold.ebi.ac.uk</ext-link> (Accessed May 28, 2024).</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moubareck</surname> <given-names>CA</given-names></name></person-group>. <article-title>Human milk microbiota and oligosaccharides: a glimpse into benefits, diversity, and correlations</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>:<fpage>1123</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu13041123</pub-id>, PMID: <pub-id pub-id-type="pmid">33805503</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quigley</surname> <given-names>L</given-names></name> <name><surname>O&#x2019;Sullivan</surname> <given-names>O</given-names></name> <name><surname>Stanton</surname> <given-names>C</given-names></name> <name><surname>Beresford</surname> <given-names>TP</given-names></name> <name><surname>Ross</surname> <given-names>RP</given-names></name> <name><surname>Fitzgerald</surname> <given-names>GF</given-names></name> <etal/></person-group>. <article-title>The complex microbiota of raw milk</article-title>. <source>FEMS Microbiol Rev</source>. (<year>2013</year>) <volume>37</volume>:<fpage>664</fpage>&#x2013;<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1574-6976.12030</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="web"><person-group person-group-type="author"><collab id="coll1">Food and Agriculture Organization of the United Nations (FAO)</collab></person-group>. (<year>2025</year>). <source>About FAO</source>. Available online at: <ext-link xlink:href="http://www.fao.org/about/zh/" ext-link-type="uri">http://www.fao.org/about/zh/</ext-link> (Accessed May 28, 2024).</citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname> <given-names>PC</given-names></name></person-group>. <article-title>Milk nutritional composition and its role in human health</article-title>. <source>Nutrition</source>. (<year>2014</year>) <volume>30</volume>:<fpage>619</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nut.2013.10.011</pub-id>, PMID: <pub-id pub-id-type="pmid">24800664</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scholz-Ahrens</surname> <given-names>KE</given-names></name> <name><surname>Ahrens</surname> <given-names>F</given-names></name> <name><surname>Barth</surname> <given-names>CA</given-names></name></person-group>. <article-title>Nutritional and health attributes of milk and milk imitations</article-title>. <source>Eur J Nutr</source>. (<year>2020</year>) <volume>59</volume>:<fpage>19</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00394-019-01936-3</pub-id>, PMID: <pub-id pub-id-type="pmid">30937581</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flis</surname> <given-names>Z</given-names></name> <name><surname>Molik</surname> <given-names>E</given-names></name></person-group>. <article-title>Importance of bioactive substances in sheep&#x2019;s milk in human health</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>:<fpage>4364</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms22094364</pub-id>, PMID: <pub-id pub-id-type="pmid">33921992</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname> <given-names>M</given-names></name> <name><surname>Jiang</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Fu</surname> <given-names>G</given-names></name> <name><surname>Zou</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Transcriptional profiling of buffalo mammary gland with different milk fat contents</article-title>. <source>Gene</source>. (<year>2021</year>) <volume>802</volume>:<fpage>145864</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.gene.2021.145864</pub-id>, PMID: <pub-id pub-id-type="pmid">34352300</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname> <given-names>TM</given-names></name> <name><surname>Zou</surname> <given-names>Z</given-names></name> <name><surname>Bansal</surname> <given-names>N</given-names></name></person-group>. <article-title>Camel milk: a review of its nutritional value, heat stability, and potential food products</article-title>. <source>Food Res Int</source>. (<year>2022</year>) <volume>153</volume>:<fpage>110870</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodres.2021.110870</pub-id>, PMID: <pub-id pub-id-type="pmid">35227464</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>N</given-names></name> <name><surname>Xie</surname> <given-names>Q</given-names></name> <name><surname>Chen</surname> <given-names>Q</given-names></name> <name><surname>Evivie</surname> <given-names>SE</given-names></name> <name><surname>Liu</surname> <given-names>D</given-names></name> <name><surname>Dong</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Cow, goat, and mare milk diets differentially modulated the immune system and gut microbiota of mice colonized by healthy infant feces</article-title>. <source>J Agric Food Chem</source>. (<year>2020</year>) <volume>68</volume>:<fpage>15345</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jafc.0c06039</pub-id>, PMID: <pub-id pub-id-type="pmid">33300339</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hachana</surname> <given-names>Y</given-names></name> <name><surname>Nasraoui</surname> <given-names>C</given-names></name> <name><surname>Frija</surname> <given-names>I</given-names></name> <name><surname>Fortina</surname> <given-names>R</given-names></name></person-group>. <article-title>Arabian mare&#x2019;s milk characterization and clotting ability</article-title>. <source>J Food Sci Technol</source>. (<year>2022</year>) <volume>59</volume>:<fpage>1840</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13197-021-05196-0</pub-id>, PMID: <pub-id pub-id-type="pmid">35531404</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Czy&#x017C;ak-Runowska</surname> <given-names>G</given-names></name> <name><surname>W&#x00F3;jtowski</surname> <given-names>JA</given-names></name> <name><surname>Dank&#x00F3;w</surname> <given-names>R</given-names></name> <name><surname>Stanis&#x0142;awski</surname> <given-names>D</given-names></name></person-group>. <article-title>Mare&#x2019;s milk from a small polish specialized farm&#x2014;basic chemical composition, fatty acid profile, and healthy lipid indices</article-title>. <source>Animals</source>. (<year>2021</year>) <volume>11</volume>:<fpage>1590</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ani11061590</pub-id>, PMID: <pub-id pub-id-type="pmid">34071465</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>L</given-names></name> <name><surname>Yang</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Zhu</surname> <given-names>Y</given-names></name> <name><surname>Meng</surname> <given-names>Q</given-names></name> <etal/></person-group>. <article-title>Impact of different dietary regimens on the lipidomic profile of mare&#x2019;s milk</article-title>. <source>Food Res Int</source>. (<year>2022</year>) <volume>156</volume>:<fpage>111305</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodres.2022.111305</pub-id>, PMID: <pub-id pub-id-type="pmid">35651065</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname> <given-names>YJ</given-names></name> <name><surname>Jhang</surname> <given-names>WL</given-names></name> <name><surname>Lee</surname> <given-names>MC</given-names></name> <name><surname>Bat-Otgon</surname> <given-names>B</given-names></name> <name><surname>Narantungalag</surname> <given-names>E</given-names></name> <name><surname>Huang</surname> <given-names>CC</given-names></name></person-group>. <article-title>Lactose-riched Mongolian mare&#x2019;s milk improves physical fatigue and exercise performance in mice</article-title>. <source>Int J Med Sci</source>. (<year>2021</year>) <volume>18</volume>:<fpage>564</fpage>&#x2013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.7150/ijms.53098</pub-id>, PMID: <pub-id pub-id-type="pmid">33390826</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaiswal</surname> <given-names>L</given-names></name> <name><surname>Worku</surname> <given-names>M</given-names></name></person-group>. <article-title>Recent perspective on cow&#x2019;s milk allergy and dairy nutrition</article-title>. <source>Crit Rev Food Sci Nutr</source>. (<year>2022</year>) <volume>62</volume>:<fpage>7503</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1080/10408398.2021.1915241</pub-id>, PMID: <pub-id pub-id-type="pmid">33983082</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martuzzi</surname> <given-names>F</given-names></name> <name><surname>Franceschi</surname> <given-names>P</given-names></name> <name><surname>Formaggioni</surname> <given-names>P</given-names></name></person-group>. <article-title>Fermented mare milk and its microorganisms for human consumption and health</article-title>. <source>Food Secur</source>. (<year>2024</year>) <volume>13</volume>:<fpage>493</fpage>. doi: <pub-id pub-id-type="doi">10.3390/foods13030493</pub-id>, PMID: <pub-id pub-id-type="pmid">38338628</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pietrzak-Fie&#x0107;ko</surname> <given-names>R</given-names></name> <name><surname>Kamelska-Sadowska</surname> <given-names>AM</given-names></name></person-group>. <article-title>The comparison of nutritional value of human milk with other mammals&#x2019; milk</article-title>. <source>Nutrients</source>. (<year>2020</year>) <volume>12</volume>:<fpage>1404</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu12051404</pub-id>, PMID: <pub-id pub-id-type="pmid">32422857</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pyles</surname> <given-names>MB</given-names></name> <name><surname>Brock</surname> <given-names>K</given-names></name> <name><surname>Schendel</surname> <given-names>RR</given-names></name> <name><surname>Lawrence</surname> <given-names>LM</given-names></name></person-group>. <article-title>Improved methods for mare milk analysis: extraction and quantification of mare milk carbohydrates and assessment of FTIR-based macronutrient quantification</article-title>. <source>Front Nutr</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1066463</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnut.2023.1066463</pub-id>, PMID: <pub-id pub-id-type="pmid">36742429</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mena-S&#x00E1;nchez</surname> <given-names>G</given-names></name> <name><surname>Becerra-Tom&#x00E1;s</surname> <given-names>N</given-names></name> <name><surname>Babio</surname> <given-names>N</given-names></name> <name><surname>Salas-Salvad&#x00F3;</surname> <given-names>J</given-names></name></person-group>. <article-title>Dairy product consumption in the prevention of metabolic syndrome: a systematic review and meta-analysis of prospective cohort studies</article-title>. <source>Adv Nutr</source>. (<year>2019</year>) <volume>10</volume>:<fpage>S144</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1093/advances/nmy083</pub-id>, PMID: <pub-id pub-id-type="pmid">31089736</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fontecha</surname> <given-names>J</given-names></name> <name><surname>Calvo</surname> <given-names>MV</given-names></name> <name><surname>Juarez</surname> <given-names>M</given-names></name> <name><surname>Gil</surname> <given-names>A</given-names></name> <name><surname>Mart&#x00ED;nez-Vizcaino</surname> <given-names>V</given-names></name></person-group>. <article-title>Milk and dairy product consumption and cardiovascular diseases: an overview of systematic reviews and meta-analyses</article-title>. <source>Adv Nutr</source>. (<year>2019</year>) <volume>10</volume>:<fpage>S164</fpage>&#x2013;<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1093/advances/nmy099</pub-id>, PMID: <pub-id pub-id-type="pmid">31089735</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Bueno</surname> <given-names>C</given-names></name> <name><surname>Cavero-Redondo</surname> <given-names>I</given-names></name> <name><surname>Martinez-Vizcaino</surname> <given-names>V</given-names></name> <name><surname>Sotos-Prieto</surname> <given-names>M</given-names></name> <name><surname>Ruiz</surname> <given-names>JR</given-names></name> <name><surname>Gil</surname> <given-names>A</given-names></name></person-group>. <article-title>Effects of milk and dairy product consumption on type 2 diabetes: overview of systematic reviews and meta-analyses</article-title>. <source>Adv Nutr</source>. (<year>2019</year>) <volume>10</volume>:<fpage>S154</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1093/advances/nmy107</pub-id>, PMID: <pub-id pub-id-type="pmid">31089734</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuesta-Triana</surname> <given-names>F</given-names></name> <name><surname>Verdejo-Bravo</surname> <given-names>C</given-names></name> <name><surname>Fern&#x00E1;ndez-P&#x00E9;rez</surname> <given-names>C</given-names></name> <name><surname>Mart&#x00ED;n-S&#x00E1;nchez</surname> <given-names>FJ</given-names></name></person-group>. <article-title>Effect of milk and other dairy products on the risk of frailty, sarcopenia, and cognitive performance decline in the elderly: a systematic review</article-title>. <source>Adv Nutr</source>. (<year>2019</year>) <volume>10</volume>:<fpage>S105</fpage>&#x2013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1093/advances/nmy105</pub-id>, PMID: <pub-id pub-id-type="pmid">31089731</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Badawy</surname> <given-names>AA</given-names></name> <name><surname>El-Hofey</surname> <given-names>SM</given-names></name> <name><surname>Shaban</surname> <given-names>AM</given-names></name> <name><surname>Orif</surname> <given-names>SE</given-names></name> <name><surname>Uyan&#x0131;kgil</surname> <given-names>Y</given-names></name> <name><surname>El-Magd</surname> <given-names>MA</given-names></name></person-group>. <article-title>Camel milk extracellular vesicles/exosomes: a fascinating frontier in isolation and therapeutic potential</article-title>. <source>Food Funct</source>. (<year>2025</year>) <volume>16</volume>:<fpage>344</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1039/d4fo04331f</pub-id>, PMID: <pub-id pub-id-type="pmid">39714264</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname> <given-names>HM</given-names></name> <name><surname>Mohammed-Geba</surname> <given-names>K</given-names></name> <name><surname>Tawfic</surname> <given-names>AA</given-names></name> <name><surname>El-Magd</surname> <given-names>MA</given-names></name></person-group>. <article-title>Camel milk exosomes modulate cyclophosphamide-induced oxidative stress and immuno-toxicity in rats</article-title>. <source>Food Funct</source>. (<year>2019</year>) <volume>10</volume>:<fpage>7523</fpage>&#x2013;<lpage>32</lpage>. doi: <pub-id pub-id-type="doi">10.1039/c9fo01914f</pub-id>, PMID: <pub-id pub-id-type="pmid">31674611</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaban</surname> <given-names>AM</given-names></name> <name><surname>Raslan</surname> <given-names>M</given-names></name> <name><surname>Sharawi</surname> <given-names>ZW</given-names></name> <name><surname>Abdelhameed</surname> <given-names>MS</given-names></name> <name><surname>Hammouda</surname> <given-names>O</given-names></name> <name><surname>El-Masry</surname> <given-names>HM</given-names></name> <etal/></person-group>. <article-title>Antibacterial, antifungal, and anticancer effects of camel milk exosomes: an in vitro study</article-title>. <source>Vet Sci</source>. (<year>2023</year>) <volume>10</volume>:<fpage>124</fpage>. doi: <pub-id pub-id-type="doi">10.3390/vetsci10020124</pub-id>, PMID: <pub-id pub-id-type="pmid">36851428</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sedykh</surname> <given-names>SE</given-names></name> <name><surname>Purvinish</surname> <given-names>LV</given-names></name> <name><surname>Monogarov</surname> <given-names>AS</given-names></name> <name><surname>Burkova</surname> <given-names>EE</given-names></name> <name><surname>Grigor&#x2019;eva</surname> <given-names>AE</given-names></name> <name><surname>Bulgakov</surname> <given-names>DV</given-names></name> <etal/></person-group>. <article-title>Purified horse milk exosomes contain an unpredictable small number of major proteins</article-title>. <source>Bioch Open</source>. (<year>2017</year>) <volume>4</volume>:<fpage>61</fpage>&#x2013;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopen.2017.02.004</pub-id>, PMID: <pub-id pub-id-type="pmid">29450143</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname> <given-names>T</given-names></name> <name><surname>Wehner</surname> <given-names>A</given-names></name> <name><surname>Schaab</surname> <given-names>C</given-names></name> <name><surname>Cox</surname> <given-names>J</given-names></name> <name><surname>Mann</surname> <given-names>M</given-names></name></person-group>. <article-title>Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins</article-title>. <source>Mol Cell Proteomics</source>. (<year>2012</year>) <volume>11</volume>:<fpage>M111.014050</fpage>. doi: <pub-id pub-id-type="doi">10.1074/mcp.M111.014050</pub-id>, PMID: <pub-id pub-id-type="pmid">22278370</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Renzone</surname> <given-names>G</given-names></name> <name><surname>Arena</surname> <given-names>S</given-names></name> <name><surname>Scaloni</surname> <given-names>A</given-names></name></person-group>. <article-title>Proteomic characterization of intermediate and advanced glycation end-products in commercial milk samples</article-title>. <source>J Proteome</source>. (<year>2015</year>) <volume>117</volume>:<fpage>12</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jprot.2014.12.021</pub-id>, PMID: <pub-id pub-id-type="pmid">25638024</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>Z</given-names></name> <name><surname>Duley</surname> <given-names>JA</given-names></name> <name><surname>Cowley</surname> <given-names>DM</given-names></name> <name><surname>Reed</surname> <given-names>S</given-names></name> <name><surname>Arachchige</surname> <given-names>BJ</given-names></name> <name><surname>Shaw</surname> <given-names>PN</given-names></name> <etal/></person-group>. <article-title>Comprehensive biochemical and proteomic characterization of seasonal Australian camel milk</article-title>. <source>Food Chem</source>. (<year>2022</year>) <volume>381</volume>:<fpage>132297</fpage>:<fpage>132297</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodchem.2022.132297</pub-id>, PMID: <pub-id pub-id-type="pmid">35124492</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>J</given-names></name> <name><surname>Mann</surname> <given-names>M</given-names></name></person-group>. <article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title>. <source>Nat Biotechnol</source>. (<year>2008</year>) <volume>26</volume>:<fpage>1367</fpage>&#x2013;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id>, PMID: <pub-id pub-id-type="pmid">19029910</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>H</given-names></name> <name><surname>Du</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Noorin</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Transcriptional activation of MdDEF30 by MdWRKY75 enhances apple resistance to Cytospora canker</article-title>. <source>J Integr Agric</source>. (<year>2024</year>):<fpage>132297</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jia.2024.06.001</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>H</given-names></name> <name><surname>Yu</surname> <given-names>H</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name> <name><surname>Cao</surname> <given-names>Z</given-names></name> <name><surname>Du</surname> <given-names>Y</given-names></name> <name><surname>Dai</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>&#x03B2;-Carboline dimers inhibit the tumor proliferation by the cell cycle arrest of sarcoma through intercalating to cyclin-A2</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<fpage>922183</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.922183</pub-id>, PMID: <pub-id pub-id-type="pmid">36325324</pub-id></citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>W</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>D</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Shen</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma</article-title>. <source>J Exp Clin Cancer Res</source>. (<year>2018</year>) <volume>37</volume>:<fpage>201</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13046-018-0880-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30153855</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>Z</given-names></name> <name><surname>Zhong</surname> <given-names>Q</given-names></name> <name><surname>Yan</surname> <given-names>X</given-names></name></person-group>. <article-title>YWHAE/14-3-3&#x03B5; crotonylation regulates leucine deprivation-induced autophagy</article-title>. <source>Autophagy</source>. (<year>2023</year>) <volume>19</volume>:<fpage>2401</fpage>&#x2013;<lpage>2</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15548627.2023.2166276</pub-id>, PMID: <pub-id pub-id-type="pmid">36628438</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanfranco</surname> <given-names>MF</given-names></name> <name><surname>Sepulveda</surname> <given-names>J</given-names></name> <name><surname>Kopetsky</surname> <given-names>G</given-names></name> <name><surname>Rebeck</surname> <given-names>GW</given-names></name></person-group>. <article-title>Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation</article-title>. <source>Glia</source>. (<year>2021</year>) <volume>69</volume>:<fpage>1478</fpage>&#x2013;<lpage>93</lpage>. doi: <pub-id pub-id-type="doi">10.1002/glia.23974</pub-id>, PMID: <pub-id pub-id-type="pmid">33556209</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christofides</surname> <given-names>A</given-names></name> <name><surname>Konstantinidou</surname> <given-names>E</given-names></name> <name><surname>Jani</surname> <given-names>C</given-names></name> <name><surname>Boussiotis</surname> <given-names>VA</given-names></name></person-group>. <article-title>The role of peroxisome proliferator-activated receptors (PPAR) in immune responses</article-title>. <source>Metabolism</source>. (<year>2021</year>) <volume>114</volume>:<fpage>154338</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.metabol.2020.154338</pub-id>, PMID: <pub-id pub-id-type="pmid">32791172</pub-id></citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname> <given-names>Q</given-names></name> <name><surname>Costa</surname> <given-names>M</given-names></name></person-group>. <article-title>Hypoxia-inducible factor-1 (HIF-1)</article-title>. <source>Mol Pharmacol</source>. (<year>2006</year>) <volume>70</volume>:<fpage>1469</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1124/mol.106.027029</pub-id>, PMID: <pub-id pub-id-type="pmid">16887934</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerber</surname> <given-names>EL</given-names></name> <name><surname>Padberg</surname> <given-names>C</given-names></name> <name><surname>Koll</surname> <given-names>N</given-names></name> <name><surname>Schuetzhold</surname> <given-names>V</given-names></name> <name><surname>Fandrey</surname> <given-names>J</given-names></name> <name><surname>Winning</surname> <given-names>S</given-names></name></person-group>. <article-title>The importance of hypoxia-inducible factors (HIF-1 and HIF-2) for the pathophysiology of inflammatory bowel disease</article-title>. <source>Int J Mol Sci</source>. (<year>2020</year>) <volume>21</volume>:<fpage>8551</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms21228551</pub-id>, PMID: <pub-id pub-id-type="pmid">33202783</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>C</given-names></name> <name><surname>Liu</surname> <given-names>Z</given-names></name> <name><surname>Xiao</surname> <given-names>J</given-names></name></person-group>. <article-title>Ferroptosis: a double-edged sword in gastrointestinal disease</article-title>. <source>Int J Mol Sci</source>. (<year>2021</year>) <volume>22</volume>:<fpage>12403</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms222212403</pub-id>, PMID: <pub-id pub-id-type="pmid">34830285</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guri</surname> <given-names>A</given-names></name> <name><surname>Paligot</surname> <given-names>M</given-names></name> <name><surname>Cr&#x00E8;vecoeur</surname> <given-names>S</given-names></name> <name><surname>Piedboeuf</surname> <given-names>B</given-names></name> <name><surname>Claes</surname> <given-names>J</given-names></name> <name><surname>Daube</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>In vitro screening of mare&#x2019;s milk antimicrobial effect and antiproliferative activity</article-title>. <source>FEMS Microbiol Lett</source>. (<year>2016</year>) <volume>363</volume>:<fpage>fnv 234</fpage>. doi: <pub-id pub-id-type="doi">10.1093/femsle/fnv234</pub-id>, PMID: <pub-id pub-id-type="pmid">26656278</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spada</surname> <given-names>V</given-names></name> <name><surname>Ferranti</surname> <given-names>P</given-names></name> <name><surname>Chianese</surname> <given-names>L</given-names></name> <name><surname>Salimei</surname> <given-names>E</given-names></name> <name><surname>Addeo</surname> <given-names>F</given-names></name> <name><surname>Picariello</surname> <given-names>G</given-names></name></person-group>. <article-title>Antibacterial potential of donkey&#x2019;s milk disclosed by untargeted proteomics</article-title>. <source>J Proteome</source>. (<year>2021</year>) <volume>231</volume>:<fpage>104007</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jprot.2020.104007</pub-id>, PMID: <pub-id pub-id-type="pmid">33038512</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname> <given-names>J</given-names></name> <name><surname>Evans</surname> <given-names>R</given-names></name> <name><surname>Pritzel</surname> <given-names>A</given-names></name> <name><surname>Green</surname> <given-names>T</given-names></name> <name><surname>Figurnov</surname> <given-names>M</given-names></name> <name><surname>Ronneberger</surname> <given-names>O</given-names></name> <etal/></person-group>. <article-title>Highly accurate protein structure prediction with AlphaFold</article-title>. <source>Nature</source>. (<year>2021</year>) <volume>596</volume>:<fpage>583</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id>, PMID: <pub-id pub-id-type="pmid">34265844</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>F</given-names></name> <name><surname>Sun</surname> <given-names>L</given-names></name> <name><surname>Kaptoge</surname> <given-names>S</given-names></name></person-group>. <article-title>Association of beta-2-microglobulin and cardiovascular events and mortality: a systematic review and meta-analysis</article-title>. <source>Atherosclerosis</source>. (<year>2021</year>) <volume>320</volume>:<fpage>70</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2021.01.018</pub-id>, PMID: <pub-id pub-id-type="pmid">33581388</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flemmig</surname> <given-names>J</given-names></name> <name><surname>Gau</surname> <given-names>J</given-names></name> <name><surname>Schlorke</surname> <given-names>D</given-names></name> <name><surname>Arnhold</surname> <given-names>J</given-names></name></person-group>. <article-title>Lactoperoxidase as a potential drug target</article-title>. <source>Expert Opin Ther Targets</source>. (<year>2016</year>) <volume>20</volume>:<fpage>447</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1517/14728222.2016.1112378</pub-id>, PMID: <pub-id pub-id-type="pmid">26558497</pub-id></citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x00F3;pez-Arvizu</surname> <given-names>A</given-names></name> <name><surname>Rocha-Mendoza</surname> <given-names>D</given-names></name> <name><surname>Farr&#x00E9;s</surname> <given-names>A</given-names></name> <name><surname>Ponce-Alquicira</surname> <given-names>E</given-names></name> <name><surname>Garc&#x00ED;a-Cano</surname> <given-names>I</given-names></name></person-group>. <article-title>Improved antimicrobial spectrum of the N-acetylmuramoyl-L-alanine amidase from Latilactobacillus sakei upon LysM domain deletion</article-title>. <source>World J Microbiol Biotechnol</source>. (<year>2021</year>) <volume>37</volume>:<fpage>196</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s11274-021-03169-1</pub-id>, PMID: <pub-id pub-id-type="pmid">34654973</pub-id></citation></ref>
<ref id="ref45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Z</given-names></name> <name><surname>Zhang</surname> <given-names>Z</given-names></name> <name><surname>Lei</surname> <given-names>Z</given-names></name> <name><surname>Lei</surname> <given-names>P</given-names></name></person-group>. <article-title>CD14: biology and role in the pathogenesis of disease</article-title>. <source>Cytokine Growth Factor Rev</source>. (<year>2019</year>) <volume>48</volume>:<fpage>24</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cytogfr.2019.06.003</pub-id>, PMID: <pub-id pub-id-type="pmid">31296363</pub-id></citation></ref>
<ref id="ref46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miraglia</surname> <given-names>N</given-names></name> <name><surname>Salimei</surname> <given-names>E</given-names></name> <name><surname>Fantuz</surname> <given-names>F</given-names></name></person-group>. <article-title>Equine milk production and valorization of marginal areas&#x2014;a review</article-title>. <source>Animals</source>. (<year>2020</year>) <volume>10</volume>:<fpage>353</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ani10020353</pub-id>, PMID: <pub-id pub-id-type="pmid">32098374</pub-id></citation></ref>
<ref id="ref47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barone</surname> <given-names>G</given-names></name> <name><surname>O&#x2019;Regan</surname> <given-names>J</given-names></name> <name><surname>Kelly</surname> <given-names>AL</given-names></name> <name><surname>O&#x2019;Mahony</surname> <given-names>JA</given-names></name></person-group>. <article-title>Interactions between whey proteins and calcium salts and implications for the formulation of dairy protein-based nutritional beverage products: a review</article-title>. <source>Compr Rev Food Sci Food Saf</source>. (<year>2022</year>) <volume>21</volume>:<fpage>1254</fpage>&#x2013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1541-4337.12884</pub-id>, PMID: <pub-id pub-id-type="pmid">35075762</pub-id></citation></ref>
<ref id="ref48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>M</given-names></name> <name><surname>Sun</surname> <given-names>J</given-names></name> <name><surname>Jiang</surname> <given-names>ZQ</given-names></name> <name><surname>Yang</surname> <given-names>YX</given-names></name></person-group>. <article-title>Effects of cow&#x2019;s milk beta-casein variants on symptoms of milk intolerance in Chinese adults: a multicentre, randomised controlled study</article-title>. <source>Nutr J</source>. (<year>2017</year>) <volume>16</volume>:<fpage>72</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12937-017-0275-0</pub-id>, PMID: <pub-id pub-id-type="pmid">29070042</pub-id></citation></ref>
<ref id="ref49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuellenberg de Gaudry</surname> <given-names>D</given-names></name> <name><surname>Lohner</surname> <given-names>S</given-names></name> <name><surname>Bischoff</surname> <given-names>K</given-names></name> <name><surname>Schmucker</surname> <given-names>C</given-names></name> <name><surname>Hoerrlein</surname> <given-names>S</given-names></name> <name><surname>Roeger</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>A1- and A2 beta-casein on health-related outcomes: a scoping review of animal studies</article-title>. <source>Eur J Nutr</source>. (<year>2022</year>) <volume>61</volume>:<fpage>1</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00394-021-02551-x</pub-id>, PMID: <pub-id pub-id-type="pmid">34075432</pub-id></citation></ref>
<ref id="ref50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname> <given-names>AS</given-names></name> <name><surname>Reed</surname> <given-names>SA</given-names></name></person-group>. <article-title>Lactation in horses</article-title>. <source>Anim Front</source>. (<year>2023</year>) <volume>13</volume>:<fpage>103</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1093/af/vfad003</pub-id>, PMID: <pub-id pub-id-type="pmid">37324210</pub-id></citation></ref>
<ref id="ref51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anjum</surname> <given-names>J</given-names></name> <name><surname>Mitra</surname> <given-names>S</given-names></name> <name><surname>Das</surname> <given-names>R</given-names></name> <name><surname>Alam</surname> <given-names>R</given-names></name> <name><surname>Mojumder</surname> <given-names>A</given-names></name> <name><surname>Emran</surname> <given-names>TB</given-names></name> <etal/></person-group>. <article-title>A renewed concept on the MAPK signaling pathway in cancers: polyphenols as a choice of therapeutics</article-title>. <source>Pharmacol Res</source>. (<year>2022</year>) <volume>184</volume>:<fpage>106398</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phrs.2022.106398</pub-id>, PMID: <pub-id pub-id-type="pmid">35988867</pub-id></citation></ref>
<ref id="ref52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname> <given-names>YJ</given-names></name> <name><surname>Feng</surname> <given-names>Y</given-names></name> <name><surname>Ma</surname> <given-names>X</given-names></name> <name><surname>Ma</surname> <given-names>F</given-names></name></person-group>. <article-title>Defensins: defenders of human reproductive health</article-title>. <source>Hum Reprod Update</source>. (<year>2023</year>) <volume>29</volume>:<fpage>126</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1093/humupd/dmac032</pub-id>, PMID: <pub-id pub-id-type="pmid">36130055</pub-id></citation></ref>
<ref id="ref53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cieslak</surname> <given-names>J</given-names></name> <name><surname>Wodas</surname> <given-names>L</given-names></name> <name><surname>Borowska</surname> <given-names>A</given-names></name> <name><surname>Sadoch</surname> <given-names>J</given-names></name> <name><surname>Pawlak</surname> <given-names>P</given-names></name> <name><surname>Puppel</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Variability of lysozyme and lactoferrin bioactive protein concentrations in equine milk in relation to LYZ and LTF gene polymorphisms and expression</article-title>. <source>J Sci Food Agric</source>. (<year>2017</year>) <volume>97</volume>:<fpage>2174</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jsfa.8026</pub-id>, PMID: <pub-id pub-id-type="pmid">27611486</pub-id></citation></ref>
<ref id="ref54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H</given-names></name> <name><surname>Hussain</surname> <given-names>T</given-names></name> <name><surname>Yao</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Sabir</surname> <given-names>N</given-names></name> <name><surname>Liao</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Koumiss promotes <italic>Mycobacterium bovis</italic> infection by disturbing intestinal flora and inhibiting endoplasmic reticulum stress</article-title>. <source>FASEB J</source>. (<year>2021</year>) <volume>35</volume>:<fpage>e21777</fpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.202002485RR</pub-id>, PMID: <pub-id pub-id-type="pmid">34403519</pub-id></citation></ref>
</ref-list>
</back>
</article>